ERNA-101 remains on track for IND-enabling studies in 2025, with first-in-human studies targeted for 2026.

Feeling Low? Your Ultra-Processed Food Habit Might Be to BlameA recent study published in Food Science & Nutrition has highlighted a strong ...

In a recent clip, Dr Jackson-Spence shared a number of different symptoms that could actually be something more serious - ...

Every year, we’re reminded of the importance of awareness, early detection, and action in the face of one of the most ...

Often overshadowed by breast and cervical cancer, ovarian cancer remains one of India's deadliest but least talked-about ...

The addition of bevacizumab to first-line (1L) chemotherapy offers real-world benefit to patients with epithelial ovarian cancer with high-risk prognostic factors.

A cancer survivor is raising awareness about the importance of genetic testing. Why she believes it can be imperative to ...

A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune responses and resist immunotherapies.

The early months of 2025 have seen a surge of research centered on cannabidiol (CBD), with studies investigating its role in ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

For ovarian cysts that cause pain, medications such as acetaminophen, ibuprofen, or another non-steroidal anti-inflammatory ...

Clinical update on LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients ...